AbbVie’s $10.9 Billion Apogee Acquisition: Pipeline Promise and Shareholder Value in Focus
Market Chameleon (Mon, 22-Jun 9:52 AM)
AbbVie’s $10.9 Billion Apogee Therapeutics Deal Signals Major Bet on Next-Generation Immunology Assets
Market Chameleon (Mon, 22-Jun 7:05 AM)
Apogee Secures $1.3 Billion Non-Dilutive Funding, Paving the Way for Zumilokibart’s Phase 3 and Commercialization
Market Chameleon (Wed, 27-May 7:05 AM)
